by Lengea Law | Oct 12, 2023 | News
In November 2022, the US Pharmacopeia (USP) released updates to their General Chapters on Compounding for sterile and non-sterile preparations that will go into effect on November 1, 2023. The question coming out of these updates is: how will they alter how I run my...
by Lengea Law | Sep 21, 2023 | News
Daxxify is a new FDA-approved neuromodulator by Revance Therapeutics (“Revance”) designed to soften the look of fine lines and wrinkles. Daxxify differs from Botox and other botulinum toxin injectables, like Xeomin, Juveau, and Dysport, in that it is designed to work...
by Lengea Law | Sep 19, 2022 | Finance & Tax Planning
This month’s biggest story in the med spa industry is the FDA’s approval of Daxxify. Is this the best thing since Botox or is it just another fall fad? The Lengea team cuts through the hype and tells you what it really means for your practice. What is Daxxify? The New...
by Lengea Law | Aug 29, 2022 | Finance & Tax Planning
For most med spas, autumn is the busiest season. That means it’s almost time to replace poolside margaritas, strappy sandals, and summer heat with pumpkin spice lattes, booties, and getting down to business. Why the Summer is Slower Generally, the...
by Lengea Law | Mar 10, 2022 | Starting a Business
There has been a rise of mobile medical spas – spas that do not have one physical location, but instead the practitioner comes to the patient’s house, place of work, or other location. This is similar to “Botox® parties” in a patient’s home or a concierge...
